Survey of the level of anti-HBs antibody titer in vaccinated Iranian general dentists

Special Care in Dentistry

Volumn 28, Issue 6, 2008, Pages 265-270

  Alavian, Seyed Moayed ^a,b   Izadi, Morteza ^c   Zare, Ali Akbar ^c   Lankarani, Maryam Moghani ^d   Assari, Shervin ^c   Vardi, Mohammad Mahdi ^b  

^a Baqiyatallah Research Center for Gastroenterology and Liver Disease   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Antibody titer; General dentists; Hepatitis B; Vaccination

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; AGE; AGED; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; DENTIST; FEMALE; GENERAL PRACTICE; HUMAN; IMMUNIZATION; IMMUNOLOGY; IRAN; MALE; MARRIAGE; MIDDLE AGED; PROFESSIONAL PRACTICE; SEX DIFFERENCE; SMOKING; URBAN POPULATION; VACCINATION;

ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; DENTISTS; FEMALE; GENERAL PRACTICE, DENTAL; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; IRAN; MALE; MARITAL STATUS; MIDDLE AGED; PROFESSIONAL PRACTICE LOCATION; SEX FACTORS; SMOKING; URBAN POPULATION; VACCINATION; YOUNG ADULT;

EID: 54849418708     PISSN: 02751879     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1754-4505.2008.00052.x     Document Type: Article

References (56)

1. Kubba AK, Taylor P, Graneek B, Strobell S. Non-response to hepatitis B vaccination: a review. Commun Dis Public Health 2003 6 : 106 12.
2. Rehermann B. Immune response in hepatitis B virus infection. Semin Liver Dis 2003 23 : 21 38.
3. Lavanchy D. Hepatitis B virus epidemiology disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004 11 : 97 107.
4. Thomas DL, Gruninger SE, Siew C, Joy ED, Quinn TC. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America. Am J Med 1996 100 : 41 5.
5. Cleveland JL, Cardo DM. Occupational exposures to human immunodeficiency virus, hepatitis B virus, and hepatitis C virus: risk, prevention, and management. Dent Clin North Am 2003 47 : 681 96.
6. Kane M. The epidemiology and control of hepatitis B as an occupational hazard in the health professions. In : Kane M, Holleran C, Andre F, eds. Proceedings of the European conference on hepatitis B and occupational hazard. London : Gower Medical Publishing 1991 10 5.
7. Smith JL, Maynard JE, Berquist KR, et al. Comparative risk of hepatitis B among physicians and dentists. J Infect Dis 1976 133 : 705 6.
8. Goh KT, Chan YW, Wong LY, et al. The prevalence of hepatitis B virus markers in dental personnel in Singapore. Trans R Soc Trop Med Hyg 1988 82 : 908 10.
9. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal child-hood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991 40 (RR-13 1 25.
10. Ammon A, Reichart PA, Pauli G, Petersen LR. Hepatitis B and C among Berlin dental personnel: incidence, risk factors, and effectiveness of barrier prevention measures. Epidemiol Infect 2000 125 : 407 13.
11. Janbakhsh A, Sayad B, Vaziri S, Aieni P. Serologic response to hepatitis B vaccine in health care workers, Kermanshah, Iran. J Res Med Sci 2005 3 : 147 9.
12. Ranjbar M, Keramat F, Keshavarz F. The immunogenicity of hepatitis B vaccine in personnel of Sina Hospital of Hamadan, Iran. Iran J Infect Dis Trop Med 2001 18 : 55 8.
13. Klewer J, Kugler J. Vaccination status of medical and dental students. Gesundheitswesen 2000 62 : 654 9.
14. Toukan AU, Sharaiha ZK, Abu-el-Rub OA, et al. The epidemiology of hepatitis B virus among family members in the Middle East. Am J Epidemiol 1990 132 : 220 32.
15. Centers for Disease Control and Prevention. Characteristics of persons with chronic hepatitis B - San Francisco, California, 2006. MMWR 2007 56 : 446 8.
16. Centers for Disease Control and Prevention. Prevention of specific infectious diseases: hepatitis, viral, type B. Travelers' health: yellow book. Accessed September 10, 2007; Available at http://www.cdc.gov/travel/ybToc.aspx.
17. Iranian Ministry of Health, Deputy of Health, Center of AIDS Control, 2001. Unpublished data.
18. Kohn WG, Collins AS, Cleveland JL, Harte JA, Eklund KJ, Malvitz DM. Guidelines for infection control in dental health-care settings - 2003. MMWR Recomm Rep 2003 52 (RR-17 1 61.
19. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population - a viral marker study. Ann Acad Med Singapore 1980 9 : 144 8.
20. Ebrahim-Poor S, Yaghoobi M, Gharamaleki V, Khoshavar H, Sakhinia E, Madadi A. Seropidemiological studies of hepatitis B and C in haemophiliacs in northwestern Iran. Irn J Med Sci 1997 22 : 126.
21. Karimi M, Ghavanini AA. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran. J Paediatr Child Health 37 : 564 6.
22. Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ, Zand V, Azami AA, Hosseini MM, Faridi AR, Davari K, Hajibeigi B. Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: a multicenter study. Arch Iran Med 2006 9 : 319 23.
23. Bagheri Lankarani K, Borhanmanesh F, Fattahi F, Malekzadeh R, Nabipoor I, Saberi-Firoozi M, Sarafrazyazdi M. Reassessment of the role of hepatitis B and C viruses in postnecrotic cirrhosis and chronic hepatitis in southern Iran. Irn J Med Sci 1999 24 : 117 21.
24. Alavian SM, Hatami S. Evaluation of the frequency of hepatitis B vaccination and some of the related factors in physicians in Tehran (Persian). J Med Council Iran 2003 21 : 204 7.
25. Duffy RE, Cleveland JL, Hutin YJ, Cardo D. Evaluating infection control practices among dentists in Valcea, Romania in 1998. Infect Control Hosp Epidemiol 2004 25 : 570 5.
26. Paton S, Zou S, Giulivi A. More should be done to protect surgical patients from intraoperative hepatitis B infection. Infect Control Hosp Epidemiol 2002 23 : 303 5.
27. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR 1991 40 (RR-13 1 25.
28. Centers for Disease Control. Hepatitis B vaccine: Fact Sheet. Accessed 17 May 2006 Available at http://www.cdc.gov/hepatitis 2006.
29. McCarthy GM, Koval JJ, John MA, MacDonald JK. Infection control practices across Canada: do dentists follow the recommendations? J Can Dent Assoc 1999 65 : 506 11.
30. Gerami Panah F, Monzavi A. Cross-infection control in dental practice in Varamin (Persian). J Islamic Dent Assoc Iran 2003 15 : 68 79.
31. Alavian SM, Akbari H, Ahmadzad-Asl M, Kazem M, Davoudi A, Tavangar H. Concerns regarding dentists' compliance in hepatitis B vaccination and infection control. Am J Infect Control 2005 33 : 428 9.
32. Habibiyan R. Efficacy of complete hepatitis B vaccination in health care workers (Persian). Shahrekord Univ Med Sci J 2003 5 : 42 7.
33. Lok AS, Lai CL, Wu PC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988 8 : 766 70.
34. Gold Y, Somech R, Mandel D, Peled Y, Reif S. Decreased immune response to hepatitis B eight years after routine vaccination in Israel. Acta Paediatr 2003 92 : 1158 62.
35. Alimonos K, Nafziger AN, Murray J, Bertino JS Jr. Prediction of response to hepatitis B vaccine in health care workers: whose titers of antibody to hepatitis B surface antigen should be determined after a three-dose series, and what are the implications in terms of cost-effectiveness? Clin Infect Dis 1998 26 : 566 71.
36. Propst T, Propst A, Lhotta K, Vogel K, Konig P. Reinforced intradermal hepatitis B vaccination in hemodialysis patients is superior in antibody response to intramuscular or subcutaneous vaccination. Am J Kidney Dis 1998 32 : 1041 5.
37. John M. Hepatitis B immunization and pos-timmunization serology. J Can Dent Assoc 2000 66 : 551 2.
38. Havlichek D Jr., Rosenman K, Simms M, Guss P. Age-related hepatitis B seroconver-sion rates in health care workers. Am J Infect Control 1997 25 : 418 20.
39. Koff RS. Hepatitis vaccines. Infect Dis Clin North Am 2001 15 : 83 95.
40. Hussain Z, Ali SS, Husain SA, Raish M, Sharma DR, Kar P. Evaluation of immunogenicity and reactogenicity of recombinant DNA hepatitis B vaccine produced in India. World J Gastroenterol 2005 11 : 7165 8.
41. Robinson WS. Hepatitis B virus and hepatitis D virus. In : Mandell GL, Douglas RG, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious disease, 5th ed. Philadelphia : Churchill Livingstone 2000 1652 85.
42. John M. Hepatitis B immunization and postimmunization serology. J Can Dent Assoc 2000 66 : 551 2.
43. Miller LG, Goldstein G, Murphy M, Ginns LC. Reversible alterations in immunoregulatory T cells in smoking. Chest 1982 5 : 526 9.
44. Rasp FL, Clawson CC, Hoidal JR, Repine JE. Reversible impairment of the adherence of alveolar macrophages from cigarette smokers. Am Rev Respir Dis 1978 118 : 979 86.
45. Laviolette M, Coulombe R, Picard S, Braquet P, Borgeat P. Decreased leukotriene B4 synthesis in smokers alveolar macrophages in vitro. J Clin Invest 1986 77 : 54 60.
46. Tollerud DJ, Clark JW, Brown LM, Neuland CY, Mann DL, Pankiw-Trost LK, Blattner WA, Hoover RN. Association of cigarette smoking with decreased numbers of circulating natural killer cells. Am Rev Respir Dis 1989 139 : 194 8.
47. Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking. Med J Aust 1983 2 : 425 9.
48. Knowles GK, Taylor P, Turner-Warwick M. A comparison of antibody responses to Admune inactivated influenza vaccine in serum and respiratory secretions of healthy non-smokers, healthy cigarette smokers and patients with chronic bronchitis. Br J Dis Chest 1981 75 : 283 90.
49. Upton LG, Barber HD. Double-gloving and the incidence of perforations during specific oral and maxillofacial surgical procedures. J Oral Maxillofac Surg 1993 51 : 261 3.
50. Utomi IL. Attitudes of Nigerian dentists towards hepatitis B vaccination and use of barrier techniques. West Afr J Med 2005 24 : 223 6.
51. Askarian M, Malekmakan L. The prevalence of needle stick injuries in medical, dental, nursing and midwifery students at the university teaching hospitals of Shiraz, Iran. Indian J Med Sci 2006 60 : 227 32.
52. Javadi AA, Mobasherizadeh S, Memarzadeh M, Mostafavizadeh K, Yazdani R, Tavakoli A. Evaluation of needle-stick injuries among health care workers in Isfahan province, Islamic Republic of Iran. East Mediterr Health J 2007 13 : 209 10.
53. Afzali H, Vali GR, Khalifeh-Soltani A. Comparative effect of intradermal and intramuscular injections of hepatitis B vaccine. Arch Iranian Med 2003 6 : 9 12.
54. Adibi P, Rezailashkajani M, Roshandel D, Behrouz N, Ansari S, Somi MH, Shahraz S, Zali MR. An economic analysis of premarriage prevention of hepatitis B transmission in Iran. BMC Infect Dis 2004 4 : 31.
55. Alavian S-M. Ministry of Health in Iran is serious about controlling hepatitis B. Hep Mon 2007 7 : 3 5.
56. Momen Heravi M, Sharif AR, Mousavi GHA. Evaluation of anti HBS antibody in vaccinated personnels of Beheshti Hospital in Kashan (Persian). Feyz 2006 10 : 11 14.